GIM
CORZ icon

Glenmede Investment Management’s Core Scientific CORZ Stock Holding History

Glenmede Investment Management’s Portfolio CORZ Stock Details CORZ Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		$851K Sell
47,440
-5,767
-11% -$84.6K ﹤0.01% 748
2025
Q2 		$908K Buy
+53,207
New +$532K ﹤0.01% 743

Other funds holding CORZ

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
PCM
Pentwater Capital Management Naples, Florida $19.3B AUM 58.13% 1-Year Est. Return
SA
Situational Awareness San Francisco, California $13.7B AUM 334.5% 1-Year Est. Return
TSC
Two Seas Capital Rye, New York $7.15B AUM 169.27% 1-Year Est. Return
JCAM
Jericho Capital Asset Management New York $6.76B AUM 88.1% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
OWP
ORG Wealth Partners Dallas, Texas $508M AUM 83.62% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Glenmede Investment Management's CORZ Position: Q3 2025 in Review

Glenmede Investment Management reduced its Core Scientific (CORZ) stake by 11% in Q3 2025, selling an estimated $84.6K and leaving 47,440 shares worth $851K. The position accounts for ﹤0.01% of the portfolio, ranked #748.

Glenmede Investment Management first reported a position in CORZ in Q2 2025 and has held it in 2 quarters since. The position peaked at $908K in Q2 2025. 336 funds tracked by Wall St. Rank hold CORZ as of Q3 2025.

  • Glenmede Investment Management held 47,440 shares of Core Scientific worth $851K as of Q3 2025.
  • Glenmede Investment Management sold 5,767 Core Scientific shares in Q3 2025, an estimated $84.6K.
  • Core Scientific made up ﹤0.01% of Glenmede Investment Management's portfolio in Q3 2025, its #748 holding.
  • Glenmede Investment Management first reported a position in Core Scientific in Q2 2025 and has held it in 2 quarters since.
  • Glenmede Investment Management's Core Scientific position peaked at $908K in Q2 2025.
  • 336 funds tracked by Wall St. Rank held Core Scientific as of Q3 2025.

Based on Glenmede Investment Management's 13F filing for Q3 2025, filed 13 Nov 2025.